Neoadjuvant strategy for stage IIIA-N2 non-small cell lung cancer: chemoradiation or chemotherapy alone?

Dongrong Situ¹, Yongbin Lin^{1

2}

Affiliations

¹ Lung Cancer Research Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
² Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Editorial

Dongrong Situ et al. J Thorac Dis. 2017 Sep.

. 2017 Sep;9(9):2746-2748.

doi: 10.21037/jtd.2017.08.23.

Dongrong Situ¹, Yongbin Lin^{1

2}

¹ Lung Cancer Research Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
² Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

1. van Meerbeeck JP. Staging of non-small cell lung cancer: consensus, controversies and challenges. Lung Cancer 2001;34 Suppl 2:S95-107. 10.1016/S0169-5002(01)00356-7 - DOI - PubMed
1. Tanner NT, Gomez M, Rainwater C, et al. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol 2012;7:365-9. 10.1097/JTO.0b013e31823a385f - DOI - PMC - PubMed
1. Veeramachaneni NK, Feins RH, Stephenson BJ, et al. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America. Ann Thorac Surg 2012;94:922-6; discussion 926-8. 10.1016/j.athoracsur.2012.04.087 - DOI - PubMed
1. van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99:442-50. 10.1093/jnci/djk093 - DOI - PubMed
1. Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379-86. 10.1016/S0140-6736(09)60737-6 - DOI - PMC - PubMed